Article: FDA to review New Drug Application for Oracea.(PIPELINE PREVIEWS)

CollaGenex Pharmaceuticals, Inc., announced that the FDA has accepted to review its New Drug Application for Oracea, an oral tetracycline medication developed to treat rosacea. The New Drug Application data was primarily based on two Phase 3 double-blinded placebo-controlled trials that demonstrated a 61% ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!